what tier are glp 1 drugs GLP-1 Costs Explained: Managing Coverage Challenges Patient education tips for GLP-1,
Description
Therefore, I think this might be the best option for patients experiencing worsening GERD due to GLP-1-induced delayed gastric emptying

Roell, J.S

Such studies should incorporate objective measures of disease activity, including endoscopic assessment, and include representative patient cohorts

I would like to express my deep appreciation to the team, with special thanks to Dr

Search string: (Glucagon-Like Peptide-1 Receptor Agonist* OR GLP-1-RA* OR GLP-1-R* OR GLP-1 Receptor Agonist* OR Liraglutide OR Semaglutide OR Tirzepatide OR Exenatide OR Exendin-4) AND (Stem Cells[Mesh] OR stem cell* OR stromal cell* OR adult progenitor cell* OR hASC OR hASCs OR ASC OR ASCs OR adipose-derived stem cell* OR ADSC* OR MSC OR mesenchymal stem cell* OR mesenchymal stromal cell* OR mesenchymal progenitor cell* OR bone-marrow derived mesenchymal stem cell* OR BD-MSC* OR umbilical cord tissue derived mesenchymal stem cell* OR UC-MSC*) The date of the search was June 30th, 2025

This is problematic as patients with raised ICP and IIH have existent clinically relevant cognitive deficits and drug therapy which exacerbates cognitive function further compromises cognition